AI in medicine: Why Switzerland is lagging behind

7 June, 2022

Coverage alert! ?

Peter Ohnemus, President & CEO of our portfolio company dacadoo was recently interviewed by Netzwoche about artificial intelligence in the medical sector.

In the article Peter Ohnemus argues, “I’m a big AI advocate and believe in their future in medicine. We’ve made great strides in recent years, such as in image recognition, and this is just the beginning. In my opinion, there will be no personalized medicine without AI. However, the buzzword AI has also been used in the past in places where it should not have been used. If we continue to do this, there will be great disappointment in the academic and commercial world.”

You can read the article in full in Netzwoche!

TempoCap is a signatory to the United Nations-supported Principles for Responsible Investment (PRI).

Stay in touch with the TempoCap team

Subscribe to our quarterly newsletter to receive news from TempoCap and our portfolio

You may unsubscribe from these communications at anytime. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy.